Topic Paragraphs
Don't delay, get your COVID-19 vaccine or booster today!
Getting vaccinated or receiving a booster if you’re already vaccinated is the best thing you can do to help protect yourself, family and friends.
Vaccines.gov
FDA 2021 Year in Review - Working for You
Featured Topics
New Era of Smarter Food Safety
A new approach to food safety that recognizes and builds on the progress made in the past but looks towards what processes and tools will be needed for the future.
Fostering Drug Competition
Increasing the availability of generic drugs helps to create competition in the marketplace, helping make treatment more affordable and increasing access to healthcare for more patients.
Combating the Opioid Crisis
FDA takes actions to combat prescription opioid abuse.
Recent Press Announcements
Recalls, Market Withdrawals, & Safety Alerts
The FDA provides information gathered from press releases and other public notices about certain recalls of FDA-regulated products. Not all recalls have press releases or are posted on this website
Jan 27
Siren Issues a Voluntary Allergy Alert on Undeclared Cashews and Almond Butter in Birthday Cake Bites
Food & Beverages
Jan 27
Blaine Labs Issues Voluntary Nationwide Recall of RevitaDerm Wound Care Gel Due to Bacterial Contamination
Drugs
Jan 26
AuroMedics Pharma LLC Issues Voluntary Nationwide Recall of Polymyxin B for Injection USP, 500,000 Unit per Vial, Due to the Presence of Particulate Matter
Drugs
Paragraph Header
FDA VOICES: PERSPECTIVES FROM FDA EXPERTS
FDA on Track to Take Actions to Address Tobacco-Related Health Disparities
FDA expects to issue proposed rules for two tobacco product standards in the spring.
What FDA’s Foods Program Achieved in 2021 to Protect Consumers and the Food Supply
Despite the unprecedented challenges we’ve all faced during the COVID-19 pandemic, 2021 was another important year for FDA's Foods Program.
Many Important Drugs Approved in 2021 as COVID-19 Pandemic Continues
CDER approved a wide variety of safe and effective new drug therapies in 2021 despite challenges brought on by the ongoing COVID-19 pandemic.
Recently Published Guidances
Jan 26
Information Requests and Discipline Review Letters Under the Generic Drug User Fee Amendments
Drugs
Jan 26
Good ANDA Submission Practices Guidance for Industry
Drugs
Jan 26
Patient Engagement in the Design and Conduct of Medical Device Clinical Studies
Biologics, Medical Devices